{"id":"NCT04841577","sponsor":"GlaxoSmithKline","briefTitle":"A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 60 Years and Above","officialTitle":"A Phase 3, Open-label, Randomized, Controlled, Multi-country Study to Evaluate the Immune Response, Safety and Reactogenicity of RSVPreF3 OA Investigational Vaccine When Co-administered With FLU-QIV Vaccine in Adults Aged 60 Years and Above","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-04-27","primaryCompletion":"2021-09-22","completion":"2022-02-08","firstPosted":"2021-04-12","resultsPosted":"2022-10-18","lastUpdate":"2024-09-03"},"enrollment":976,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Respiratory Syncytial Virus Infections"],"interventions":[{"type":"BIOLOGICAL","name":"RSVPreF3 OA investigational vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"FLU-QIV","otherNames":[]}],"arms":[{"label":"Co-Ad Group","type":"EXPERIMENTAL"},{"label":"Control Group","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to assess the immunogenicity, safety and reactogenicity of the RSVPreF3 OA investigational vaccine when co-administered with the seasonal quadrivalent influenza vaccine (FLU-QIV) in adults aged 60 years and above compared to separate administration of the vaccines.","primaryOutcome":{"measure":"RSV-A Neutralization Antibody Titers Expressed as Geometric Mean Titers (GMTs)","timeFrame":"At 1 month after the RSV_PreF3 OA investigational vaccine dose (at Day 31 for the Co-Ad Group and at Day 61 for the Control Group)","effectByArm":[{"arm":"Co-Ad Group","deltaMin":10060.5,"sd":null},{"arm":"Control Group","deltaMin":12255,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"60 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":4,"exclusionCount":20},"locations":{"siteCount":14,"countries":["New Zealand","Panama","South Africa"]},"refs":{"pmids":["38189778"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":15,"n":442},"commonTop":["Injection site pain","Fatigue","Headache","Myalgia","Arthralgia"]}}